Global Psoriasis Clinical Trial Pipeline Highlights 2019-2024 - ResearchAndMarkets.com

DUBLIN--()--The "Global Psoriasis Clinical Trial Pipeline Highlights - 2019" report has been added to ResearchAndMarkets.com's offering.

Psoriasis Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Psoriasis market. It covers emerging therapies for Psoriasis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Psoriasis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Psoriasis pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Psoriasis pipeline products by the company.

Short-term Launch Highlights:

Find out which Psoriasis pipeline products will be launched in the US and Ex-US till 2024.

Summary:

  • Psoriasis phase 3 clinical trial pipeline products
  • Psoriasis phase 2 clinical trial pipeline products
  • Psoriasis phase 1 clinical trial pipeline products
  • Psoriasis preclinical research pipeline products
  • Psoriasis discovery stage pipeline products
  • Psoriasis pipeline products short-term launch highlights

Key Topics Covered:

1. Psoriasis Pipeline by Stages

2. Psoriasis Phase 3 Clinical Trial Insights

3. Psoriasis Phase 2 Clinical Trial Insights

4. Psoriasis Phase 1 Clinical Trial Insights

5. Psoriasis Preclinical Research Insights

6. Psoriasis Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/iu4min

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Clinical Trials, Psoriasis Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Immune Disorders Drugs, Clinical Trials, Psoriasis Drugs